In-vitro studies with four new antifungal agents: BAY n7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002
- 1 January 1984
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 22 (1) , 7-15
- https://doi.org/10.1080/00362178485380041
Abstract
Four new antifungal agents were compared in vitro with miconazole and ketoconazole. The agents were BAY n 7133 and ICI 153,066, two orally active triazoles, and bifonazole (BAY h 4502) and Ro 14-4767/002, both topical agents. While all four were found to be broad spectrum antifungal agents they also demonstrated certain gaps in their spectra. In general, Ro 14-4767/002 was the most active agent tested whereas bifonazole and BAY n 7133 were the least active. Noteworthy activities included that of Ro 14-4767/002 against Candida albicans , the dermatophytes and Sporothrix schenckii and that of ICI 153,066 against Torulopsis glabrata .Keywords
This publication has 3 references indexed in Scilit:
- In-vitro studies of a new oral azole antimycotic, BAY N 7133Journal of Antimicrobial Chemotherapy, 1983
- In-vitroinhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and bay l 9139Medical Mycology, 1983
- A comparison of bifonazole (bay h 4502) with clotrimazolein vitroMedical Mycology, 1982